Cases 71 - 80 of 331
Anacor Pharmaceuticals, LLC, et al., v. Dr. Reddys Laboratories, Ltd., et al.,
as 1:2021cv01348
Plaintiff:
Anacor Pharmaceuticals, Inc., PF PRISM IMB B.V. and Anacor Pharmaceuticals, LLC
Defendant:
Alkem Laboratories Ltd., Dr. Reddys Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MEDICURE INTERNATIONAL, INC. v. AUROBINDO PHARMA LIMITED et al
as 2:2021cv17534
Counter Defendant:
MEDICURE INTERNATIONAL, INC.
Counter Claimant:
AUROBINDO PHARMA LIMITED and AUROBINDO PHARMA USA INC.
Defendant:
EUGIA PHARMA SPECIALITIES LIMITED and AUROMEDICS PHARMA LLC
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. et al v. Macleods Pharmaceuticals Ltd. et al.
as 1:2021cv01350
Plaintiff:
Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V.
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2021cv01330
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alkem Laboratories Ltd., Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv01062
Plaintiff:
Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. AUROBINDO PHARMA LTD. et al
as 3:2021cv13240
Plaintiff:
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. and AUSPEX PHARMACEUTICALS, INC.
Defendant:
AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LTD.
Cause Of Action: 35 U.S.C. § 271
Newron Pharmaceuticals S.p.A et al v. MSN Laboratories Private Limited et al
as 1:2021cv00843
Defendant:
Aurobindo Pharma USA Inc., Prinston Pharmaceutical, Inc., MSN Laboratories Private Limited and others
Plaintiff:
Newron Pharmaceuticals S.p.A., MDD US Operations, LLC and Zambon S.p.A.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. et al v. Aurobindo Pharma Limited et al
as 1:2021cv00662
Defendant:
Aurobindo Pharma USA Inc. and Aurobindo Pharma Limited
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
SUPERNUS PHARMACEUTICALS, INC. v. AJANTA PHARMA LIMITED et al
as 3:2021cv06964
Plaintiff:
SUPERNUS PHARMACEUTICALS, INC.
Defendant:
AJANTA PHARMA LIMITED and AJANTA PHARMA USA INC.
Cause Of Action: 35 U.S.C. § 271
Astellas Pharma Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv00425
Defendant:
Teva Pharmaceuticals USA, Inc., Cadila Healthcare Ltd. doing business as Zydus Cadila, Actavis LLC and others
Plaintiff:
Astellas Pharma Global Development, Inc., Astellas Pharma Inc. and Astellas Ireland Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
